AI Drug Side Effect Prediction via Molecular Embeddings

The patent segments the prediction system into multiple specialized machine learning models: a molecular structure analysis model that processes drug molecular graphs, a patient profile analysis model that processes electronic health records, and a side effect prediction model that integrates both. This segmentation allows each model to specialize in specific data types while collectively achieving personalized prediction accuracy that accounts for individual patient variations.

The patent transforms molecular structure data into molecular embedding vectors and patient health record data into patient embedding vectors through neural network processing. These parameter transformations convert raw data into standardized representations that can be effectively combined and analyzed for personalized side effect prediction, enabling the system to handle individual patient variations.

The patent introduces embedding vectors as intermediary representations between raw molecular structure data/patient health records and the final side effect prediction. The molecular embedding vector captures drug-specific features while the patient embedding vector captures patient-specific characteristics. These intermediaries enable reliable personalized predictions by systematically integrating multiple data sources without requiring direct complex interactions between all input elements.

The patent employs universal embedding vector representations that can accommodate different molecular structures and diverse patient profiles within a unified framework. The same neural network architecture processes both molecular data and patient health record data, converting them into compatible vector formats that can be combined for prediction. This multi-functional approach maintains reliability across different input types while managing system complexity through architectural consistency.